Ruben A. Mesa, MD
@mpdrc
Clinical Leader, Advocate Health Cancer National Service Line & Exec Director AH Wake Forest Baptist Comprehensive Cancer Center. #MPNs (Tweets-My Opinion)
Today I join >600 Physicians & Scientists & thousands of team members of @WakeCancer & @LevineCancer joined as one @theNCI Comprehensive Cancer Center - world class cancer care, research & training decreasing cancer burden in the Carolinas & beyond @AtriumHealth @AtriumHealthWFB
Honored & humbled to receive #BeutlerPrize along w/#RadekSkoda. Measuring #MPN Symptoms & developing the 4 JAKi = #TEAM of dedicated MPN Patients/Investigators/#PharmaColleagues @harrisoncn1 #SergeVerstovsek @jjkiladjian #Vannuchi @RobynScherber #JoyceNiblack @wakeforestmed
ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏 🔗 ow.ly/EsgX50WbEwx #Hematology #ASHAwards
The MPN Journal helps patients track symptoms, fatigue, and medications, all in one place. 📲 👉🏻 Prof. Ruben Mesa (@mpdrc) has reviewed the tool and recommends it to patients: “I encourage MPN patients to look at this resource.” Share it! → gmpnsf.org/post/what-does… #MPNsm
At some point, someone invested in us. Now it’s our turn. Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care. @ASH_hematology @b_avalos_MD @BloodGlobalHema @BloodPortfolio donate.hematology.org/s/
🔎 A fully loaded #PPLC2025 session on all things #myelofibrosis & #mpnsm Mahalo for the insight ! & clinical nuggets of Drs. @doctorpemm, @mpdrc, @lauracmichaelis, @myeloidmalig - for walking us through 🔄 evolving strategies in disease modification—from combos ➕ to immune…
“Every time any study in this country has been done on financial toxicity, we recognize that it is an independent risk factor for both survival and for quality of life,” Thomas Knight (@wakeforestmed) said to The Cancer Letter. cancerletter.com/clinical/20250…
👉👉 Very informative slide on approval of JAKi in myelofibrosis by Dr Mesa @mpdrc #2025PPLC @doctorpemm @myeloidmalig @lauracmichaelis
Hematologists are problem-solvers. I’m proud to join my friend and colleague Dr. Belinda Avalos (@b_avalos_MD) support the #Fight4Hematology to fund bold research and training that pushes our field forward. Donate Now donate.hematology.org/s/ @ASH_hematology
Fantastic discussion!!! Amazed at the @ASH_hematology 's efforts on advocacy!! #Fight4Hematology @acweyand @mpdrc @SurbhiSidanaMD
ASH Committee on Communications Summer 2025 meeting complete! Energized to strengthen our Fight4Hematology campaign & advocacy efforts protecting federal funding for hematology research. The future of hematology care depends on continued innovation. #ASH #Fight4Hematology
Looking for better patient-reported outcomes in MPN? ✅ The MPN Journal is a new tracking tool developed by patients, in collaboration with @gmpnsf. 🧠 Track symptoms, treatment, lifestyle 🌍 11 languages 🔒 100% anonymous 🔗 gmpnsf.org/post/mpn-journ… #MPNsm @mpdrc
Exciting capabilities and great discussion! #AdvancingHealthcare @RasuShrestha #AdvocateHealth @AtriumHealth @wakeforestmed
Insightful panel at #SamsungHealth Forum with @SamsungMobileUS Dr. Hon Pak, @xealthinc’s Mike McSherry, @advocatehealth’s Dr. Rasu Shrestha and @HingeHealth’s Jim Purlsey talking the future of healthcare. Exciting things on the horizon! #Innovation
💰#Cancer costs hit hard no matter your income bracket 🔊Dr. Ruben Mesa @mpdrc @WakeCenter shows how a #financialtoxicity tumor board offers relief for patients who don’t “need to be at 300% of the federal #povertyline to qualify.” bit.ly/4ll8K1c
Celebrating a major milestone for the expansion of our Transplant and Cellular Therapy Program to Out patient Transplants - @mpdrc oncodaily.com/blog/ruben-mes… #OncoDaily #Oncology #Cancer #Health #Medicine
Nike Onifade Reflects on Her Journey and New Role at Advocate Health as an Integral Part of REWIRE2030 Strategy @advocatehealth @mpdrc oncodaily.com/blog/advocate-… #Cancer #Oncology #OncoDaily #Health #Medicine @CancerWorldmag
This weekend, check out the latest interviews from #EHA2025 and #ASCO25 with @SusanBal9, @mpdrc, @Dr_AmerZeidan, and many more! ➡️ buff.ly/0cUyjbH
Excited to Visit Cancer Care Sites Delivering World-Class Care in Wisconsin - Ruben Mesa (@mpdrc) oncodaily.com/blog/cancer-ca… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews @CancerWorldmag
Ruben Mesa Welcomes Nike Onifade as Administrative Leader for Advocate Health Cancer Service Line @mpdrc oncodaily.com/blog/ruben-mes… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #AdvocateHealth
It was fantastic to hear the topline results of the SURPASS-ET trial from Ruben Mesa (@mpdrc) at #EHA2025: 👉 ow.ly/kbvt50WfCNm Dr Mesa is the course director of the MPN Workshop of the Carolinas, which we are excited to cover again later this year!🩸 #MPNsm #HemOnc
Winn Awards Shared 2025 Winn CIPP Site Locations @WinnAwards @AtriumHealth @wakeforestmed @StJudeResearch @StJude @fredhutch @CedarsSinai @LSUHealthNO @mayscancer @MountSinaiNYC @NewYorkUni @the_lundquist @UCLA_CTSI @uofl @VCUMassey @mpdrc oncodaily.com/blog/winn-cipp… #Cancer…
👉👉👉Congratulations & shout out to Prof Ruben Mesa MD .@mpdrc & Prof Radek Skoda on being named for the major award for the #ErnestBeutler Lecture & Prize 🏆 🏅 by @ASH_hematology for 2025 !! 🙌 | #JAK2 #MPNSymptomBurden | #MPNSM | @harrisoncn1 @jjkiladjian @MpncoD @HemeReports
Congrats to our cancer program leader Dr. Ruben Mesa (@mpdrc) on earning the prestigious Ernest Beutler Lecture and Prize! Dr. Mesa has been a pioneer in the groundbreaking research & development of new therapies for myeloproliferative neoplasms (MPNs). @AtriumHealthWFB
ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏 🔗 ow.ly/EsgX50WbEwx #Hematology #ASHAwards